Member Info for DRB83

It's because most tests pick up the ORF1ab gene so most current tests including LFT'S pick up the variant. Therefore DA is not making a big song and dance about it. We were probably one of the first to RNS that we can pick up all current variants. To ncyt this is not big news. Now when the SNPsig is released that can specifically identify Omicron then I expect bells, tassles, whistles and flashing lights. How long from Delta being identified did it take us to develop the SNPsig for Delta. Anyone know?

Can't lose really. If Covid stays the SP flounders around for a little extra whilst the cash pile grows significantly. If Covid goes then we finally get to tell the market how we are going to use our cash pile to blow the doors of mid cap status. Covid come or covid go, the medium to long term outlook for the ncyt sp is way above these levels.

Steve, there are certain risks with the Omicron variant that could allow it to evade antibodies. Those risks are known with the Delta but currently unknown with Omicron. That is why the gov want to track it and that is what SNPsig and sequencing was created for.

Only way of suspecting a case of Omicron is from the Thermofisher test as it is a unique flaw in it that catches a s gene drop out. Other than that it is sequencing which can take several days at best. By which time you've already passed it round to umpteen other people. Track and trace is the definition of a dog chasing it's tail. To be safe, until they know more they should treat all positives as Omicron until proved otherwise.

Thanks for the link Larry. Ah a week ahead of schedule. No i don't think they have to wait but wasn't sure if there was a benefit to waiting or not. Something is holding it back and it's certainly not clear. Let's hope it is as simple as onboarding other products into the same process. Maybe getting it ready for non-covid use also. We'll see

Just an honest assessment BB. They called it red and even stated the SP. If you're going to slate them when they call it wrong then at least be consistent and recognise when they get it right. SP movements don't reflect the fundamentals and that is why I'm here.

I'm worried about ShelllDonald guys, she keeps talking to Porky when he's not there. As she always been like this or is trying to pick the ncyt tops and bottoms really getting to her.

Can't deny that. In the face of all the positive sentiment when peer pressure was swaying everyone north, and all other derampers were staying in bed, Ken and Woody did indeed call it right. I would be interested to here their views on the coming week.

Co prep should get it's official registration next Friday according to a piece that Exmex posted earlier in the week.

Just the way it is Uggy. Not a lot of room in business for heart and ncyt arn't legally obliged to tell us anything for the time being. It doesn't mean the building blocks arn't being laid though. The news will come. Have faith.

Hi lads n lasses,

A lot of folk on here moaning and constantly worrying about the SP. It's not healthy. If I said, when that dispute resolution comes II's will be buying in here at £7 a pop, would you agree. If so, then what does it matter what the SP does Monday, next week or even next month. Yes blue would be great but see it like a short term savings account with a 200% interest rate. Sound in the knowledge that behind those closed doors DA and his band of merry men are beavering away growing our revenue, cash, products, distribution channels, reputation. The fundamentals here are sound, the intrinsic value should allow you to sleep safe in the knowledge that your money is safe. It's all imo but that is how I feel about ncyt. It is a bottom drawer share for me.

DA has no urgent need to address us PI's and I can't see that changing anytime soon. The MM's, traders and shorters have dug in and won't be going anywhere until the dispute is resolved. Soak it up, check in every now and again and wait patiently for the next RNS. We have way more good things going for us than bad so chances are it will be a positive RNS the next one.

Sounds like a great incentive to keep the SP low until the options are divided out. Always makes me wonder with these kind of terms.

Pecten, You don't own the shares when you are short so this has nothing to do with js being short. Rediculous.

That would make sense. Thanks

Oh, so you think he may have traded. Why the switch from shares to financial instrument. Any ideas?

The latest RNS, where do OMI get the extra 7m shares from? Are they from the vault so to speak? Or will they need to buy them from the market?

Yep, looks like a transfer of part of his holdings from shares to a financial instrument under Spreadex. Not savvy enough as to why? Anyone else?

We also need to find out soon what we have done or plan to do with the £30m.of stock we have written off. I would love to know the issue. If you can't shift £30m tests at cost in the middle of a global pandemic then hang your heads in shame. If we can then that is all bonus to the bottom line.

In H1 we reported a loss of £12m. Let's say we sell £50m in H2 at 40%, that's £20m so FY a £8m EBITDA.

It won't look great so we could really do with getting something back for the £30m stock. We also need some agreement on the dispute so we can release the £41m back in as well. £80m EBITDA sounds so much better.

Tkr, there will be a tolerance. Guidance as we have it is £100m give or take £10m. So we could go to £110m possibly even £115m without updating the guidance. Afterall, it is only a guide. I expect £100m to be beaten come the Jan update.

Cream floats to the top. The more the market gets regulated the more market share ncyt will get. Simples

Soder, I understand the process around accrued/deferred revenue but how would you suppose ncyt delay any recent orders and book them as 2022 revenues. Not sure how that makes for good business. Surely you take on as many orders as you can and deliver on them orders as fast as you can. Speed of delivery is a competitive advantage in this highly competitive market. We can't be intentionally delaying delivery just so we can stick to the FY21 guidance and get a head start on FY22. Doesn't work that way. The customer just goes elsewhere lining the pockets of our competition.